Fundamental Analysis of AbbVie Inc - Growth / Value Index
ABBV - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0.397
Tsr Value Index - Poor Score of 20.31
Price to Book Ratio of 25.96 suggesting that it is very expensive
Book Value in last 3 years is trending down
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 48.59 | 59.76 | 141.74 % | |
| Price to Book | 25.67 | 27.95 | 65.14 % | 36.26 |
| Price to Sales | 5.36 | 5.35 | 6.15 % | |
| Enterprise Value to EBITDA Multiple | 20.66 | 21.36 | 22.56 % |
ABBV - Profitability Highlights
Profitability Analysis
Over the last 3 years, the company has achieved Incredible Return on Equity
Excellent QoQ /QoQ FY EPS growth
Company Earning excess return
During the past twelve months, the company has given a strong Return On Equity of 50.85%
Piotroski F Score - Stable Value of 5.0
Reasonable Dividend Yield of 3.77 %
Good Net Margin of 11.03% is achieved by the company
Low Earning Yield of 2.04 %
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 50.85 | 46.94 | -31.57 % | 13.22 |
| Return On Asset | 4.33 | 3.61 | -57.66 % | 0.924 |
| Net Profit Margin | 11.03 | 8.95 | -56.09 % | 11.17 |
| Operating Profit Margin | 25.73 | 24.92 | -23.11 % | 28.02 |
| EBITDA Margin | 30.00 | 29.06 | -15.18 % | 45.68 |
Highlights
| Market Cap | 290591 M |
| Enterprise Value | 337162 M |
| Price/Book TTM | 25.67 |
| Outstanding Share | 1765.87 M |
| Float/ Outstanding Share | 99.79% |
| Dividend Yield | 3.73 % |
Share Holding
Guru Numbers
| Price/Graham No | 7.77 |
| Peter Lynch Ratio | -1.21 |
| Piotroski F Score | 5.00 |
| Altman Z Score | 1.93 |
| Sloan Ratio | -0.119 |
| Peter Lynch Fair Value | 46.37 |
ABBV - Growth Highlights
Growth Analysis
Tsr Growth Index - Very Poor Score of 15.14
Company's Total Assets is Decreasing for last 3 years
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 54403.00 M | 6.44 % | 13.92 % |
| Gross Profit | 35850.00 M | 16.58 % | 18.48 % |
| EBITDA | 16320.50 M | 20.64 % | 62.44 % |
| Net Profit | 5999.00 M | 58.91 % | 67.27 % |
| EPS | 3.39 | 58.63 % | NA |
ABBV - Stability Highlights
Stability Analysis
Tsr Stability Index - Very Poor Score of 15.62
Company has high debt burden
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 5.73 | 56.32 % | 7.12 |
| Cash Ratio | 0.339 | 8.40 % | |
| Quick Ratio | 0.764 | -9.33 % | 0.206 |
| Shareholders Equity | 7.69 | -38.13 % | |
| Debt to EBITDA | 3.76 | 18.27 % |
Historical Valuation Ratios of AbbVie Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of AbbVie Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of AbbVie Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of AbbVie Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)